True. But the stakes are very high. This was DLL3 high (not just positive) population. Their downstream trials (2L, maintenance, 1L) are (I believe) in positive, which makes it harder now.. but obviously, also better populations in terms of performance, etc. But this is not looking good for those downstream trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.